BioClinica acquires CardioNow unit from Agfa
This article was originally published in Clinica
Clinical trial services firm BioClinica has bought the CardioNow web-based system for managing medical images from Agfa Healthcare. This deal allows BioClinica to “manage every step of the process that begins once a medical image is acquired at a clinical site through the delivery of evaluated results to the sponsor”. With the use of the CardioNow technology, Newtown, Pennsylvania-based BioClinica will be able to simplify and enhance the process of sharing, tracking and archiving medical images for clinical trials. Financial terms of the deal were not disclosed.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals